Hei comments on adult stem cell research

Jan. 27, 2011

Derek Hei, PhD, director of Waisman Biomanufacturing was quoted extensively in the January 20th issue of the Isthmus. Located at the Waisman Center, the biomanufacturing facility produces clinical-grade stem-cell lines for public and private researchers. The article highlights the differences between embryonic, adult, and iPS stem cells and discusses the potential research value of each. “Understanding why they’re different is one of the biggest challenges we face,” says Hei.

Read the entire article here: